Psychosocial Support for Nitrous Oxide Misuse

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-65
SponsorQueen Mary University of London

About this trial

Nitrous oxide (laughing gas, N₂O) is the third most commonly used recreational drug among young people in the UK. Although it may seem harmless, frequent use can damage the nerves and spinal cord. Vitamin B12 injections can help treat these neurological complications, but continued N₂O use can reduce how effective this treatment is.

Some people use N₂O to cope with stress or emotional difficulties, while others may find it hard to stop because of cravings or habits. These emotional and social difficulties can negatively affect recovery, wellbeing, and quality of life.

Our team has developed a new brief support programme for people experiencing mild to moderate emotional and social difficulties related to N₂O use. The programme provides information and practical strategies to help people cope, manage emotions, and prevent problems from worsening. It is delivered by a trained facilitator over up to four weekly sessions, either in-person or remotely.

In this study, the support programme will be introduced to patients attending the Royal London Hospital clinic for N₂O related neurological harms. Ten participants will receive the programme alongside their usual care. Participants will complete questionnaires before and after the programme to monitor mental health, quality of life, and dependence on N₂O. The research team will evaluate whether the programme was delivered as intended and whether participants remained engaged. Participants will be invited to take part in an interview to feedback on their experiences and suggest improvements before the programme is tested in a larger study. Participation will last up to 8 hours in total over approximately 9 weeks.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Confirmed clinical neurological diagnosis related to N₂O use.

Experiencing mild to moderate psychological distress.

Aged 16-65 years.

Able to communicate in English.

Disqualifiers

Other causes of neurological symptoms.

Currently receiving another structured psychosocial intervention.

Severe psychiatric distress.

Trial design

Design model

Single group

Treatments tested in this trial

  • Psychosocial intervention

    Behavioral

    A brief manualised psychosocial intervention comprising information provision, psychoeducation, goal setting, coping strategies, self-management strategies, and Cognitive Behavioural Therapy techniques (Inc. Mindfulness, cognitive reframing). The intervention will be tailored to individual needs, informed by questionnaire results, goal setting, homework activities, and open discussion.

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Psychosocial interventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility response rate

Response rates

Time frame
12 months
2

Feasibility uptake

Study uptake

Time frame
12 months
3

Feasibility drop out

Drop outs and completion

Time frame
12 months

Secondary outcomes

1

Fidelity accuracy

Accuracy of intervention delivery (mapped from intervention record forms and worksheets, case notes of intervention sessions).

Time frame
12 months
2

Fidelity quality

Quality of intervention delivery (mapped from intervention record forms and worksheets, case notes of intervention sessions).

Time frame
12 months
3

Acceptability

Qualitative interviews will capture perceived importance and acceptability of intervention.

Time frame
12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: